Wang, Ruoting
Olier, Ivan
Ortega-Martorell, Sandra
Liu, Yingxin
Ye, Zebing
Lip, Gregory YH
Li, Guowei
Funding for this research was provided by:
Science Foundation of Guangdong Second Provincial General Hospital (YY2018-002)
National Natural Science Foundation of China (82103906)
Article History
Received: 13 July 2022
Accepted: 19 September 2022
First Online: 13 October 2022
Declarations
:
: The UK Biobank study was approved by the North West Multicenter Research Ethics Committee. All participants provided written consent before enrolment.
: Not applicable.
: GYHL has served as a consultant for Novartis, Bayer/Janssen, Biotronik, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Verseon, and Daiichi-Sankyo and as a speaker for Medtronic, Bayer, BMS/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo. No fees have been received directly or personally. All other authors have declared no conflicts of interest.